- Home
- CNTB vs AEI Comparison
CNTB vs AEI Comparison
Compare CNTB & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTB | AEI |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.6M | 119.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNTB | AEI |
|---|---|---|
| Price | $2.69 | $2.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 90.3K | 29.9K |
| Earning Date | 04-02-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $762,000.00 | ★ $12,108,028.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $24,739.01 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $0.70 |
| 52 Week High | $3.28 | $4.55 |
Technical Indicators
Market Signals| Indicator | CNTB | AEI |
|---|---|---|
| Relative Strength Index (RSI) | 52.37 | 43.51 |
| Support Level | $2.46 | $2.49 |
| Resistance Level | $2.70 | $3.06 |
| Average True Range (ATR) | 0.25 | 0.32 |
| MACD | 0.02 | -0.06 |
| Stochastic Oscillator | 57.89 | 14.81 |
Price Performance
Historical ComparisonAbout CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.